Q08334 (I10R2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 124.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Interleukin-10 receptor subunit beta Short name=IL-10 receptor subunit beta Short name=IL-10R subunit beta Short name=IL-10RB Alternative name(s): Cytokine receptor class-II member 4 Cytokine receptor family 2 member 4 Short name=CRF2-4 Interleukin-10 receptor subunit 2 Short name=IL-10R subunit 2 Short name=IL-10R2 CD_antigen=CDw210b | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 325 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Shared cell surface receptor required for the activation of five class 2 cytokines: IL10, IL22, IL26, IL28, and IFNL1. Ref.9 |
| Subcellular location | |
| Polymorphism | Genetic variations in IL10RB influence susceptibility to hepatitis B virus (HBV) infection [MIM:610424]. |
| Involvement in disease | Inflammatory bowel disease 25 (IBD25) [MIM:612567]: A chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology. It is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but most frequently it involves the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints. |
| Sequence similarities | Belongs to the type II cytokine receptor family. Contains 1 fibronectin type-III domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Signal Transmembrane Transmembrane helix |
| Molecular function | Receptor |
| PTM | Disulfide bond Glycoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | immune response Traceable author statement PubMed 9463407. Source: ProtInc inflammatory responseTraceable author statement PubMed 10954742. Source: ProtInc signal transductionTraceable author statement PubMed 10954742. Source: ProtInc |
| Cellular_component | interleukin-28 receptor complex Non-traceable author statement PubMed 12483210. Source: UniProtKB |
| Molecular_function | receptor activity Traceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 19 | 19 | Ref.6 | |||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 20 – 325 | 306 | Interleukin-10 receptor subunit beta | PRO_0000011014 | ||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 20 – 220 | 201 | Extracellular Potential | |||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 221 – 242 | 22 | Helical; Potential | |||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 243 – 325 | 83 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 113 – 205 | 93 | Fibronectin type-III | |||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 49 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 68 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 102 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 161 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 66 ↔ 74 | Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 188 ↔ 209 | Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 47 | 1 | K → E Associated with susceptibility to HBV infection; higher cell surface levels. Ref.4 Ref.10 Corresponds to variant rs2834167 [ dbSNP | Ensembl ]. | VAR_020666 | ||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 124 | 1 | A → D in AAA86872. Ref.2 | |||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 243 | 1 | A → S in CAA78933. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 243 | 1 | A → S in AAA86872. Ref.2 | |||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 269 – 273 | 5 | FLGHP → VGRME in AAA86872. Ref.2 | |||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 274 – 325 | 52 | Missing in AAA86872. Ref.2 | |||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 25 – 32 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 35 – 41 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 46 – 48 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 51 – 58 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 61 – 75 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 81 – 83 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 85 – 93 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 101 – 105 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 107 – 110 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 117 – 123 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 126 – 132 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 135 – 137 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 144 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 145 – 148 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 153 – 160 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 167 – 169 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 172 – 178 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 186 – 194 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 196 – 198 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 208 – 211 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 215 – 217 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A new member of the cytokine receptor gene family maps on chromosome 21 at less than 35 kb from IFNAR." Lutfalla G., Gardiner K., Uze G. Genomics 16:366-373(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Fetal brain. |
| [2] | "Structure of the human CRFB4 gene: comparison with its IFNAR neighbor." Lutfalla G., McInnis M.G., Antonarakis S.E., Uze G. J. Mol. Evol. 41:338-344(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | SeattleSNPs variation discovery resource Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT GLU-47. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [6] | "Signal peptide prediction based on analysis of experimentally verified cleavage sites." Zhang Z., Henzel W.J. Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 20-34. |
| [7] | "Identification and functional characterization of a second chain of the interleukin-10 receptor complex." Kotenko S.V., Krause C.D., Izotova L.S., Pollack B.P., Wu W., Pestka S. EMBO J. 16:5894-5903(1997) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION. |
| [8] | "Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R." Xie M.-H., Aggarwal S., Ho W.-H., Foster J., Zhang Z., Stinson J., Wood W.I., Goddard A.D., Gurney A.L. J. Biol. Chem. 275:31335-31339(2000) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION. |
| [9] | "The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain." Donnelly R.P., Sheikh F., Kotenko S.V., Dickensheets H. J. Leukoc. Biol. 76:314-321(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence." Frodsham A.J., Zhang L., Dumpis U., Taib N.A.M., Best S., Durham A., Hennig B.J.W., Hellier S., Knapp S., Wright M., Chiaramonte M., Bell J.I., Graves M., Whittle H.C., Thomas H.C., Thursz M.R., Hill A.V.S. Proc. Natl. Acad. Sci. U.S.A. 103:9148-9153(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO HBV INFECTION, VARIANT GLU-47, CHARACTERIZATION OF VARIANT GLU-47. |
| [11] | "Inflammatory bowel disease and mutations affecting the interleukin-10 receptor." Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schaffer A.A., Noyan F., Perro M., Diestelhorst J., Allroth A., Murugan D., Hatscher N., Pfeifer D., Sykora K.W., Sauer M., Kreipe H., Lacher M., Nustede R., Woellner C. Klein C.N. Engl. J. Med. 361:2033-2045(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN IBD25. |
| [12] | "Structure and mechanism of receptor sharing by the IL-10R2 common chain." Yoon S.I., Jones B.C., Logsdon N.J., Harris B.D., Deshpande A., Radaeva S., Halloran B.A., Gao B., Walter M.R. Structure 18:638-648(2010) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.14 ANGSTROMS) OF 20-220, DISULFIDE BONDS. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | Z17227 mRNA. Translation: CAA78933.1. U08988 Genomic DNA. Translation: AAA86872.1. BT009777 mRNA. Translation: AAP88779.1. AY323826 Genomic DNA. Translation: AAP72016.1. BC001903 mRNA. Translation: AAH01903.1. | ||||||||||||
| IPI | IPI00646217. | ||||||||||||
| PIR | A47003. | ||||||||||||
| RefSeq | NP_000619.3. NM_000628.4. | ||||||||||||
| UniGene | Hs.654593. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q08334. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-6016N. | ||||||||||||
| STRING | 9606.ENSP00000290200. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q08334. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 56757647. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q08334. | ||||||||||||
| PRIDE | Q08334. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 3588. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000290200; ENSP00000290200; ENSG00000243646. | ||||||||||||
| GeneID | 3588. | ||||||||||||
| KEGG | hsa:3588. | ||||||||||||
| UCSC | uc002yrh.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 3588. | ||||||||||||
| GeneCards | GC21P034638. | ||||||||||||
| H-InvDB | HIX0213245. | ||||||||||||
| HGNC | HGNC:5965. IL10RB. | ||||||||||||
| HPA | CAB020670. | ||||||||||||
| MIM | 123889. gene. 610424. phenotype. 612567. phenotype. | ||||||||||||
| neXtProt | NX_Q08334. | ||||||||||||
| Orphanet | 238569. Autosomal recessive early-onset inflammatory bowel disease. | ||||||||||||
| PharmGKB | PA29780. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG47180. | ||||||||||||
| HOVERGEN | HBG052057. | ||||||||||||
| InParanoid | Q08334. | ||||||||||||
| KO | K05135. | ||||||||||||
| OMA | SDENDVF. | ||||||||||||
| OrthoDB | EOG4H19W1. | ||||||||||||
| PhylomeDB | Q08334. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q08334. | ||||||||||||
| Bgee | Q08334. | ||||||||||||
| CleanEx | HS_IL10RB. | ||||||||||||
| Genevestigator | Q08334. | ||||||||||||
| GermOnline | ENSG00000159113. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 1 hit. | ||||||||||||
| InterPro | IPR003961. Fibronectin_type3. IPR013783. Ig-like_fold. IPR015373. Interferon_alpha/beta_rcpt_bsu. [Graphical view] | ||||||||||||
| Pfam | PF09294. Interfer-bind. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00060. FN3. 2 hits. [Graphical view] | ||||||||||||
| SUPFAM | SSF49265. FN_III-like. 2 hits. | ||||||||||||
| PROSITE | PS50853. FN3. False negative. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | IL10RB. human. | ||||||||||||
| EvolutionaryTrace | Q08334. | ||||||||||||
| GenomeRNAi | 3588. | ||||||||||||
| NextBio | 14019. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | I10R2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q08334 Secondary accession number(s): Q9BUU4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 21 Human chromosome 21: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
